Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179569 · ClinicalTrials.gov registry record · Phase 2
Molecular Processes of the Relaxation Response in Older Adults
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00179569 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT00179569, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the molecular (nitric oxide) and biochemical (epinephrine, norepinephrine, cortisol and ACTH) parameters that are associated with RR elicitation and which may counteract the effects of acute stress in the elderly.
Interventions
- BEHAVIORAL Relaxation response
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179569
The ClinicalTrials.gov registry entry for NCT00179569 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relaxation response is the first listed.
NCT00179569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179569 about?
NCT00179569 is a clinical study titled "Molecular Processes of the Relaxation Response in Older Adults". The purpose of this study is to examine the molecular (nitric oxide) and biochemical (epinephrine, norepinephrine, cortisol and ACTH) parameters that are associated with RR elicitation and which may counteract the effects of acute stress in the elderly.
What is the current status of trial NCT00179569?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2005-08. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00179569?
The interventions under investigation include: Relaxation response (BEHAVIORAL).
Who is sponsoring clinical trial NCT00179569?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.